GB9220715D0 - Immunopotentiatory agent and physiologically acceptable salts thereof - Google Patents

Immunopotentiatory agent and physiologically acceptable salts thereof

Info

Publication number
GB9220715D0
GB9220715D0 GB929220715A GB9220715A GB9220715D0 GB 9220715 D0 GB9220715 D0 GB 9220715D0 GB 929220715 A GB929220715 A GB 929220715A GB 9220715 A GB9220715 A GB 9220715A GB 9220715 D0 GB9220715 D0 GB 9220715D0
Authority
GB
United Kingdom
Prior art keywords
immunopotentiatory
agent
acceptable salts
physiologically acceptable
physiologically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929220715A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to GB929220715A priority Critical patent/GB9220715D0/en
Publication of GB9220715D0 publication Critical patent/GB9220715D0/en
Priority to ES93307373T priority patent/ES2096215T3/es
Priority to SG1996004981A priority patent/SG48993A1/en
Priority to EP95110267A priority patent/EP0678298A3/en
Priority to EP93307373A priority patent/EP0609606B1/en
Priority to DE69306545T priority patent/DE69306545T2/de
Priority to DK93307373.6T priority patent/DK0609606T3/da
Priority to AT93307373T priority patent/ATE146075T1/de
Priority to TW82108031A priority patent/TW251234B/zh
Priority to IL107157A priority patent/IL107157A0/xx
Priority to CZ941327A priority patent/CZ132794A3/cs
Priority to MX9306079A priority patent/MX9306079A/es
Priority to JP6508846A priority patent/JPH07504204A/ja
Priority to HR931243A priority patent/HRP931243A2/hr
Priority to CA002124677A priority patent/CA2124677C/en
Priority to CNB931144442A priority patent/CN1213746C/zh
Priority to KR1019940701840A priority patent/KR100348775B1/ko
Priority to AU48311/93A priority patent/AU676491B2/en
Priority to PCT/GB1993/002039 priority patent/WO1994007479A2/en
Priority to YU62793A priority patent/YU62793A/sh
Priority to HU9401631A priority patent/HUT70482A/hu
Priority to ZA937286A priority patent/ZA937286B/xx
Priority to SI9300514A priority patent/SI9300514A/sl
Priority to JP27730093A priority patent/JP3717950B2/ja
Priority to NZ256110A priority patent/NZ256110A/en
Priority to SK652-94A priority patent/SK65294A3/sk
Priority to RU94028670/14A priority patent/RU94028670A/ru
Priority to EP93921034A priority patent/EP0614357A1/en
Priority to US08/446,080 priority patent/US5508310A/en
Priority to US08/460,207 priority patent/US6096786A/en
Priority to GR970400229T priority patent/GR3022541T3/el
Priority to US08/813,915 priority patent/US5872151A/en
Pending legal-status Critical Current

Links

GB929220715A 1992-10-01 1992-10-01 Immunopotentiatory agent and physiologically acceptable salts thereof Pending GB9220715D0 (en)

Priority Applications (32)

Application Number Priority Date Filing Date Title
GB929220715A GB9220715D0 (en) 1992-10-01 1992-10-01 Immunopotentiatory agent and physiologically acceptable salts thereof
ES93307373T ES2096215T3 (es) 1992-10-01 1993-09-17 Tucaresol como agente inmunopotenciador.
SG1996004981A SG48993A1 (en) 1992-10-01 1993-09-17 Immunopotentiatory agent and physiologically acceptable salts thereof
EP95110267A EP0678298A3 (en) 1992-10-01 1993-09-17 Use of 4- (2-formyl-3-hydroxyphenoxymethyl) benzoic acid as an immunopotentiating agent.
EP93307373A EP0609606B1 (en) 1992-10-01 1993-09-17 Tucaresol as an immunopotentiatory agent
DE69306545T DE69306545T2 (de) 1992-10-01 1993-09-17 Tucaresol als Mittel zur Immunopotentierung
DK93307373.6T DK0609606T3 (enrdf_load_stackoverflow) 1992-10-01 1993-09-17
AT93307373T ATE146075T1 (de) 1992-10-01 1993-09-17 Tucaresol als mittel zur immunopotentierung
TW82108031A TW251234B (enrdf_load_stackoverflow) 1992-10-01 1993-09-29
IL107157A IL107157A0 (en) 1992-10-01 1993-09-29 Immunopotentiatory agents and pharmaceutical compositions comprising them
EP93921034A EP0614357A1 (en) 1992-10-01 1993-09-30 Immunopotentiatory agents
CA002124677A CA2124677C (en) 1992-10-01 1993-09-30 Immunopotentiatory agents and physiologically acceptable salts thereof
ZA937286A ZA937286B (en) 1992-10-01 1993-09-30 Immunopotentiatory agents and physiologically acceptable salts thereof
JP6508846A JPH07504204A (ja) 1992-10-01 1993-09-30 免疫増強剤およびその生理的に容認可能な塩
HR931243A HRP931243A2 (en) 1992-10-01 1993-09-30 Immunopotentiatory agent and pppphysiologically acceptable salts eof
CZ941327A CZ132794A3 (en) 1992-10-01 1993-09-30 Immunopotentiating preparation
CNB931144442A CN1213746C (zh) 1992-10-01 1993-09-30 免疫强化剂及其生理上可接受的盐
KR1019940701840A KR100348775B1 (ko) 1992-10-01 1993-09-30 면역강화제
AU48311/93A AU676491B2 (en) 1992-10-01 1993-09-30 Immunopotentiatory agents
PCT/GB1993/002039 WO1994007479A2 (en) 1992-10-01 1993-09-30 Immunopotentiatory agents
YU62793A YU62793A (sh) 1992-10-01 1993-09-30 Nova primena jedinjenja i njihovih fizioloških prihvatljivih soli za pojačavanje imuniteta
HU9401631A HUT70482A (en) 1992-10-01 1993-09-30 Immunopotentiatory pharmaceutical compositions containing carbonylgroups
MX9306079A MX9306079A (es) 1992-10-01 1993-09-30 Agente inmunopotenciador y sus sales fisiologicamente aceptables.
SI9300514A SI9300514A (en) 1992-10-01 1993-09-30 Immunopotentiatory agent and physiologically acceptable salts thereof
JP27730093A JP3717950B2 (ja) 1992-10-01 1993-09-30 免疫強化剤及び生理学的に許容され得るその塩
NZ256110A NZ256110A (en) 1992-10-01 1993-09-30 Use of a compound which forms a schiff base or hydrazone for the preparation of a medicament
SK652-94A SK65294A3 (en) 1992-10-01 1993-09-30 Immunopotentiatory agent
RU94028670/14A RU94028670A (ru) 1992-10-01 1993-09-30 Иммунопотенциирующие агенты, способы лечения иммунодефицитных млекопитающих, а также вирусных инфекций и рака у млекопитающих
US08/446,080 US5508310A (en) 1992-10-01 1995-05-19 Immunopotentiatory agents and physiologically acceptable salts thereof
US08/460,207 US6096786A (en) 1992-10-01 1995-06-02 Immunopotentiatory agent and physiologically acceptable salts thereof
GR970400229T GR3022541T3 (en) 1992-10-01 1997-02-12 Tucaresol as an immunopotentiatory agent.
US08/813,915 US5872151A (en) 1992-10-01 1997-03-07 Immunopotentiatory agents and physiologically acceptable salts thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929220715A GB9220715D0 (en) 1992-10-01 1992-10-01 Immunopotentiatory agent and physiologically acceptable salts thereof

Publications (1)

Publication Number Publication Date
GB9220715D0 true GB9220715D0 (en) 1992-11-11

Family

ID=10722825

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929220715A Pending GB9220715D0 (en) 1992-10-01 1992-10-01 Immunopotentiatory agent and physiologically acceptable salts thereof

Country Status (3)

Country Link
GB (1) GB9220715D0 (enrdf_load_stackoverflow)
TW (1) TW251234B (enrdf_load_stackoverflow)
ZA (1) ZA937286B (enrdf_load_stackoverflow)

Also Published As

Publication number Publication date
TW251234B (enrdf_load_stackoverflow) 1995-07-11
ZA937286B (en) 1995-06-30

Similar Documents

Publication Publication Date Title
GR3023258T3 (en) 3-Aryl-4-hydroxy-delta3-dihydrofuranone and 3-aryl-4-hydroxy-delta3-dihydrothiophenone derivatives
ZA923516B (en) New thiopyranopyrrole derivatives and their preparation
IL114795A0 (en) N-benzylindole- and benmzopyrazole derivatives their preparation and use
EP0498268A3 (en) 5-oxo-l-proline derivatives and pharmaceutical use thereof
HU9400190D0 (en) Therapeutic compositions and methods
EP0482649A3 (en) Cm-chitin derivatives and use thereof
AP9300555A0 (en) Therapeutic agent and its use
IL116190A0 (en) Eleutherobin and analogs thereof
HU9500003D0 (en) Fungicidal 2-imidazoline-5-one and 2-imidazoline-5-thione derivatives
ZA943649B (en) Piperidine derivatives their preparation and use
ZA92729B (en) Pharmaceutical agent
EP0462021A3 (en) Cholesterol-lowering agents and veterinary cholesterol-lowering agents
ZA932576B (en) 1,2,4-benzothiadiazine-3-carboxylic acid derivatives, their preparation and their use
HU9204072D0 (en) Terazole derivatives and medical preparatives containing them
GB9220715D0 (en) Immunopotentiatory agent and physiologically acceptable salts thereof
GB9226874D0 (en) Immunopotentiatory agents and physiologically acceptable salts thereof
NZ248041A (en) Aminoalkyl- tetrahydrofuran derivatives and medicaments
IL114333A0 (en) Pyrimidinyl- and triazinyl-oxy-and-thio-3-haloalkyl-propionic acid derivatives their preparation and use
ZA935430B (en) 5 S penem derivatives their preparation and use
ZA924842B (en) Asialoglycoprotein-conjugated medicinal agent
GB9112058D0 (en) Therapeutic agent
GB9110342D0 (en) Therapeutic agent
GB9122204D0 (en) Therapeutic agent
ZA956025B (en) 1-arylpyrimidine derivatives and pharmaceutical use thereof
GB9113622D0 (en) Medicinal agents